These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23708468)

  • 21. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
    Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of cognitive and behavioural therapies for methamphetamine dependence.
    Lee NK; Rawson RA
    Drug Alcohol Rev; 2008 May; 27(3):309-17. PubMed ID: 18368613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups.
    Rawson RA; Gonzales R; Greenwell L; Chalk M
    J Psychoactive Drugs; 2012; 44(4):342-9. PubMed ID: 23210383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of methamphetamine abuse treatment: Predictors of treatment completion and comparison of two residential treatment programs.
    Kamp F; Proebstl L; Hager L; Schreiber A; Riebschläger M; Neumann S; Straif M; Schacht-Jablonowsky M; Manz K; Soyka M; Koller G
    Drug Alcohol Depend; 2019 Aug; 201():8-15. PubMed ID: 31154239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period.
    Gonzales R; Ang A; Marinelli-Casey P; Glik DC; Iguchi MY; Rawson RA;
    J Subst Abuse Treat; 2009 Dec; 37(4):353-61. PubMed ID: 19553066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A community-engaged randomized controlled trial of an integrative intervention with HIV-positive, methamphetamine-using men who have sex with men.
    Carrico AW; Jain J; Discepola MV; Olem D; Andrews R; Woods WJ; Neilands TB; Shoptaw S; Gómez W; Dilworth SE; Moskowitz JT
    BMC Public Health; 2016 Jul; 16():673. PubMed ID: 27476110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility and acceptability of approach bias modification during methamphetamine withdrawal and related methamphetamine use outcomes.
    Manning V; Garfield JBB; Mroz K; Campbell SC; Piercy H; Staiger PK; Lum JAG; Lubman DI; Verdejo-Garcia A
    J Subst Abuse Treat; 2019 Nov; 106():12-18. PubMed ID: 31540606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
    Stauffer CS; Moschetto JM; McKernan SM; Hsiang E; Borsari B; Woolley JD
    Trials; 2019 Feb; 20(1):145. PubMed ID: 30791944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contingency management: an evidence-based component of methamphetamine use disorder treatments.
    Roll JM
    Addiction; 2007 Apr; 102 Suppl 1():114-20. PubMed ID: 17493060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana use.
    Alessi SM; Rash C; Petry NM
    Drug Alcohol Depend; 2011 Oct; 118(1):62-7. PubMed ID: 21440999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antisocial personality disorder predicts methamphetamine treatment outcomes in homeless, substance-dependent men who have sex with men.
    Fletcher JB; Reback CJ
    J Subst Abuse Treat; 2013 Sep; 45(3):266-72. PubMed ID: 23579078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Course of Methamphetamine-Induced Psychotic Disorder in a 3-Month Follow-Up.
    Javadian S; Shabani A; Shariat SV
    Prim Care Companion CNS Disord; 2016 Nov; 18(6):. PubMed ID: 27907276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
    BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative and isomeric determination of amphetamine and methamphetamine from urine using a nonprotic elution solvent and R(-)-alpha-methoxy-alpha-trifluoromethylphenylacetic acid chloride derivatization.
    Holler JM; Vorce SP; Bosy TZ; Jacobs A
    J Anal Toxicol; 2005 Oct; 29(7):652-7. PubMed ID: 16419395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Identification of Methamphetamine Abuse and Selegiline Use： Chiral Analysis of Methamphetamine and Amphetamine in Urine].
    Xiang P; Bu J; Qiao Z; Zhuo XY; Wu HJ; Shen M
    Fa Yi Xue Za Zhi; 2017 Dec; 33(6):599-603. PubMed ID: 29441766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modafinil for the treatment of methamphetamine dependence.
    Anderson AL; Li SH; Biswas K; McSherry F; Holmes T; Iturriaga E; Kahn R; Chiang N; Beresford T; Campbell J; Haning W; Mawhinney J; McCann M; Rawson R; Stock C; Weis D; Yu E; Elkashef AM
    Drug Alcohol Depend; 2012 Jan; 120(1-3):135-41. PubMed ID: 21840138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contingency management treatment for methamphetamine use disorder in South Africa.
    Okafor CN; Stein DJ; Dannatt L; Ipser J; van Nunen LJ; Lake MT; Krishnamurti T; London ED; Shoptaw S
    Drug Alcohol Rev; 2020 Mar; 39(3):216-222. PubMed ID: 31863530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.